Cargando…

VHL-Mediated Regulation of CHCHD4 and Mitochondrial Function

Dysregulated mitochondrial function is associated with the pathology of a wide range of diseases including renal disease and cancer. Thus, investigating regulators of mitochondrial function is of particular interest. Previous work has shown that the von Hippel-Lindau tumor suppressor protein (pVHL)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Briston, Thomas, Stephen, Jenna M., Thomas, Luke W., Esposito, Cinzia, Chung, Yuen-Li, Syafruddin, Saiful E., Turmaine, Mark, Maddalena, Lucas A., Greef, Basma, Szabadkai, Gyorgy, Maxwell, Patrick H., Vanharanta, Sakari, Ashcroft, Margaret
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180203/ https://www.ncbi.nlm.nih.gov/pubmed/30338240 http://dx.doi.org/10.3389/fonc.2018.00388

Ejemplares similares

Corrigendum: VHL-Mediated Regulation of CHCHD4 and Mitochondrial Function
por: Briston, Thomas, et al.
Publicado: (2021)

CHCHD4 regulates tumour proliferation and EMT-related phenotypes, through respiratory chain-mediated metabolism
por: Thomas, Luke W., et al.
Publicado: (2019)

CHCHD4 Regulates Intracellular Oxygenation and Perinuclear Distribution of Mitochondria
por: Thomas, Luke W., et al.
Publicado: (2017)

Corrigendum: CHCHD4 Regulates Intracellular Oxygenation and Perinuclear Distribution of Mitochondria
por: Thomas, Luke W., et al.
Publicado: (2019)

CHCHD4 confers metabolic vulnerabilities to tumour cells through its control of the mitochondrial respiratory chain
por: Thomas, Luke W., et al.
Publicado: (2019)

CHCHD4 (MIA40) and the mitochondrial disulfide relay system
por: Al-Habib, Hasan, et al.
Publicado: (2021)

The mitochondrial oxidoreductase CHCHD4 is present in a semi-oxidized state in vivo
por: Erdogan, Alican J., et al.
Publicado: (2018)

Endogenous HIF2A reporter systems for high-throughput functional screening
por: Zaini, M. Nazhif, et al.
Publicado: (2018)

CHCHD2 and CHCHD10 regulate mitochondrial dynamics and integrated stress response
por: Ruan, Yu, et al.
Publicado: (2022)

Neurodegeneration-associated mitochondrial proteins, CHCHD2 and CHCHD10–what distinguishes the two?
por: Ikeda, Aya, et al.
Publicado: (2022)

Epigenetic expansion of VHL-HIF signal output drives multi-organ metastasis in renal cancer
por: Vanharanta, Sakari, et al.
Publicado: (2012)

CHCHD2 and CHCHD10: Future therapeutic targets in cognitive disorder and motor neuron disorder
por: Jiang, Tianlin, et al.
Publicado: (2022)

Mitochondrial permeability transition pore: sensitivity to opening and mechanistic dependence on substrate availability
por: Briston, Thomas, et al.
Publicado: (2017)

Cancer Cell-Derived PDGFB Stimulates mTORC1 Activation in Renal Carcinoma
por: Abuhamad, Asmaa Y., et al.
Publicado: (2023)

PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction
por: Zhou, Wei, et al.
Publicado: (2019)

CHCHD2 connects mitochondrial metabolism to apoptosis
por: Liu, Yong, et al.
Publicado: (2015)

Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson’s Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia
por: Imai, Yuzuru, et al.
Publicado: (2019)

A hypoxic ticket to the bone metastatic niche
por: Vanharanta, Sakari
Publicado: (2015)

Chchd10 is dispensable for myogenesis but critical for adipose browning
por: Xia, Wei, et al.
Publicado: (2022)

FRI118 3D Reconstruction Of Mitochondria From Human Heart Failure Structures Is Associated With Alterations In CHCHD6 And CHCHD3 Expression
por: Gail Marshall, Andrea, et al.
Publicado: (2023)

Identification of 3 novel VHL germ-line mutations in Danish VHL patients
por: Dandanell, Mette, et al.
Publicado: (2012)

Genome-wide CRISPR/Cas9 deletion screen defines mitochondrial gene essentiality and identifies routes for tumour cell viability in hypoxia
por: Thomas, Luke W., et al.
Publicado: (2021)

Neuropathologic description of CHCHD10 mutated amyotrophic lateral sclerosis
por: Keith, Julia L., et al.
Publicado: (2020)

CHCHD2: The Power House's Potential Prognostic Factor for Cancer?
por: Gundamaraju, Rohit, et al.
Publicado: (2021)

Deciphering von Hippel-Lindau (VHL/Vhl)-Associated Pancreatic Manifestations by Inactivating Vhl in Specific Pancreatic Cell Populations
por: Shen, H.-C. Jennifer, et al.
Publicado: (2009)

Determination of the consequences of VHL mutations on VHL transcripts in renal cell carcinoma
por: TAYLOR, CLAIRE, et al.
Publicado: (2012)

A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma
por: Syafruddin, Saiful E., et al.
Publicado: (2019)

Epigenetic determinants of metastasis
por: Patel, Saroor A., et al.
Publicado: (2017)

Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene
por: Wykoff, C C, et al.
Publicado: (2004)

Thioamide substitution to probe the hydroxyproline recognition of VHL ligands
por: Soares, Pedro, et al.
Publicado: (2018)

Mitofilin and CHCHD6 physically interact with Sam50 to sustain cristae structure
por: Ding, Chengli, et al.
Publicado: (2015)

A Deletion Downstream of the CHCHD7 Gene Is Associated with Growth Traits in Sheep
por: Xu, Hongwei, et al.
Publicado: (2020)

CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma
por: McRonald, Fiona E, et al.
Publicado: (2009)

Computational and Experimental Characterization of dVHL Establish a Drosophila Model of VHL Syndrome
por: Shmueli, Merav D., et al.
Publicado: (2014)

Identification of ER-000444793, a Cyclophilin D-independent inhibitor of mitochondrial permeability transition, using a high-throughput screen in cryopreserved mitochondria
por: Briston, Thomas, et al.
Publicado: (2016)

VHL-P138R and VHL-L163R Novel Variants: Mechanisms of VHL Pathogenicity Involving HIF-Dependent and HIF-Independent Actions
por: Mathó, Cecilia, et al.
Publicado: (2022)

Early-onset Parkinson disease caused by a mutation in CHCHD2 and mitochondrial dysfunction
por: Lee, Richard G., et al.
Publicado: (2018)

Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity
por: Woo, Jung-A. A., et al.
Publicado: (2017)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson’s disease
por: Liu, Xiaodan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3bmp4m8pkhmh3d33nbm63jco4c